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Abstract This study was designed to examine morpho-
logical features in a large group of children with autism
spectrum disorder versus normal controls. Amongst 421
patients and 1,007 controls, 224 matched pairs were cre-
ated. Prevalence rates and odds ratios were analyzed by
conditional regression analysis, McNemar test or paired
t-test matched pairs. Morphological abnormalities were
signiﬁcantly more prevalent in patients with autism than in
the normal control group and 48 morphological features
distinguished patients from controls. Our ﬁndings show
that morphological features are associated with autism.
Exploring potential underlying genetic mechanisms of this
association might lead to a better understanding of autism.
Keywords Minor anomalies  Common variants 
Dysmorphology  Heterogeneity  Etiology 
Biological marker
Introduction
Autism Spectrum Disorder (ASD) is a neurodevelopmental
disorder characterized by qualitative impairments in social
interaction and communication skills, accompanied by
repetitive and stereotyped behaviors and interests (APA
2000). Family and twin studies have shown that the risk for
autism is largely determined by genetic factors ([90%)
(Geschwind and Levitt 2007). However, the pattern of
inheritance is not straightforward and may include additive
effects of common risk alleles, rare gene mutations
(e.g., fragile-X) chromosomal abnormalities (e.g., copy
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insults (Mendelsohn and Schaefer 2008). Despite the sig-
niﬁcant heritability, ﬁnding the cause has been daunting
due to genetic complexity and phenotypic variation
(Szatmari et al. 2007; Abrahams and Geschwind 2008).
Such heterogeneity in autism has led researchers to seek for
reliable diagnostic tools to create genetically homogenous
subgroups.
The study of head circumference and other morpho-
logical characteristics has begun to merge into autism
research to stratify ASDs into more homogenous sub-
groups. Excessive head growth found in the ﬁrst year of
life, in children later diagnosed with autism, has been one
of the most promising quantitative traits (Miles et al.
2000; Sacco et al. 2007). With respect to other morpho-
logical characteristics, an excess of minor physical
anomalies (MPAs) in autistic individuals received speciﬁc
attention (Ozgen et al. 2010). Although in the psychiatric
literature the term ‘‘MPAs’’ is generally accepted, mor-
phological features encompass major abnormalities as
well as minor variants (Aase 1990; Merks et al. 2008).
Minor variants are deﬁned as slight morphological devi-
ations that have no serious medical or cosmetic signiﬁ-
cance, however, they are of great value to the clinician
because (1) they can be utilized as indicators of under-
lying disease susceptibility or markers of disturbed
development (e.g., they are found to be more common in
individuals with an obvious major embryonic defect; Aase
1990; McGrath et al. 2002); (2) They serve as external
indicators of neurodevelopment because of the close
relationship between cerebral and craniofacial develop-
ment (Hammond et al. 2008); (3) Topography of mor-
phological features could provide clues to the process of
ASDs as they reﬂect adverse events during critical periods
of development, usually within the ﬁrst and second tri-
mester (Lane et al. 1997). Minor variants that are
observed in 4% or less of the normal population are
termed minor anomalies, and those occurring in more
than 4% of the normal population are termed common
variants.
There is now robust evidence for the association
between morphological abnormalities and autism (Ozgen
et al. 2010). Existing studies, however, are limited by a
number of methodological constrains: a. lack of stan-
dardization of the nomenclature and the absence of uni-
form diagnostic criteria; b. patients with different ethnic
backgrounds were included; c. patients were not physi-
cally examined by the investigators speciﬁcally for the
study; d. lack of control data or use of biased populations
(e.g., hospital-based cohorts); e. relatively small sample
sizes; f. no reports on interrater reliability; g. lack of
consideration on gender effect. Moreover, the majority of
studies that have assessed the incidence of morphological
abnormalities in autism used the Waldrop scale (vide
infra), with occasional modiﬁcations and omissions of
items (Waldrop et al. 1968; Ismail et al. 1998). While the
Waldrop scale is able to distinguish patients from con-
trols, it has been criticized for inherent limitations
regarding content and form; i.e., its restricted range of 18
items and low sensitivity (Lane et al. 1997).
With these caveats in mind, here we present an approach
to study morphological features in a large sample of chil-
dren with autism and a matched-case control group by
using detailed deﬁnitions of the phenotype and an inter-
nationally accepted classifying list of 683 morphological
features (Merks et al. 2003).
Method
Participants
We examined all consecutive patients attending the
Department of Child and Adolescent Psychiatry (CAP) of
the University Medical Center in Utrecht, the Nether-
lands. This hospital provides health services to a wide
range of patients from mainly the centre and south of the
Netherlands. During the study period, patients and/or their
caregivers were invited in writing to participate both to
psychological assessments as to a physical examination.
The participants in the ASD group were included only if
they had a documented diagnosis of an autistic spectrum
disorder (autistic disorder, Asperger’s disorder or PDD-
NOS). Consensus diagnoses were made for each case,
consisting of a developmental history, medical examina-
tion, and a structured DSM-IV psychiatric interview by
experienced child psychiatrists and conﬁrmed by using
ADI-R (Lord et al. 1994). Children with any known
syndrome or with mental retardation (ICD-9 codes
317–319; IQ\70; Smith and Bostian 1964; Rodier et al.
1997) were excluded. Ethnicity was registered because it
can inﬂuence the external phenotype (McGrath et al.
2002; Merks et al. 2008). 1,007 controls were examined
and analyzed in an identical way. Controls were recruited
from the city of Haarlem and the surrounding semirural
and rural area, because the region was found to be an
excellent representative of the general health proﬁle in the
Netherlands (Cluitmans et al. 2002; Van Lier 2004;
Merks et al. 2006).
The study procedures were approved at the medical
ethics committee (METC) of the University Medical
Center, Utrecht, the Netherlands. Patients and controls
entered the study only after written informed consent was
obtained from themselves and/or their parents.
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123Terminology and Classiﬁcation of Morphological
Characteristics
A hierarchical tree was built, comprising 29 major ana-
tomical areas, subdivided into 98 different structures, and
containing 683 standardized morphological abnormalities.
The morphological abnormalities were classiﬁed according
to their (presumed) pathogenesis, and subdivided into (a)
Major abnormalities, caused by abnormal development;
and (b) Minor variants. The minor variants can be subdi-
vided into two categories, based on their prevalence in the
normal population: Minor anomalies, having a prevalence
in the normal population by deﬁnition of B4%; and Com-
mon variants, having by deﬁnition a prevalence in the
normal population of [4% (Supp. Fig. 1; Aase 1990;
Merks et al. 2003).
Morphological Examination (Qualitative and
Quantitative measures)
All patients and controls were carefully examined in an
identical way by the same trained examiner (HMO). The
clinical examination consisted of standard morphological
measurements and comprised a broad range of qualitative
and quantitative physical measurements. All items in the
Waldrop-scale were included in this list and a clear dif-
ferentiation between major abnormalities, minor anomalies
and common variants were introduced. It should be
emphasized that the distinction between major and minor
anomalies is pragmatic, and only deﬁned by the effect on
the child. Techniques and standards of measurement were
adapted from the studies by Aase (1990) and Hall and Hall
(2007). Height, weight, head circumference, inner and
outer canthal distance, ear length, hand length and palm
length were measured and shoe size was converted into
foot length. The location of some of these quantitative
measurements is displayed in Supp. Fig. 2. No speciﬁc
equipment other than a ruler and measuring tape was used.
Auscultation of the heart, abdominal palpation, examina-
tion of internal organs and of the external genitalia was not
performed. Body mass index (BMI) is formulated as
weight (kg)/height (m)
2 and interpreted with the reference
of Van Buuren (2004). Palpebral ﬁssure length (PFL) is
deﬁned as the distance between the inner and outer canthus
of one eye (Hall and Hall 2007).
Reliability studies were conducted using a second
observer (FAB, clinical geneticist/pediatrician) who
examined 30 patients (9%) of the ASD group, blind to the
patients’ diagnosis and to the results of morphological
assessment of the ﬁrst examiner. This resulted in a kappa
score of 0.81 (Cohen 1960). For the controls, 111 children
(11%) were examined by a second observer (RCH)
resulting in a kappa score of 0.85. Assessors were blinded
to family status and to any previous diagnosis at the time of
the assessment.
Data Analysis
To better determine whether patients with ASD had higher
prevalence of dysmorphology we compared each of the
quantitative and qualitative items in carefully selected
matched pairs. To reduce the inﬂuence of ethnic variability
in the matched pairs, analyses were restricted to Caucasian
patients and controls. We used procedures in SPSS to
match as many patients with autism as possible to controls
based on sex and age (±2 years). When more than one
control was available for matching to a case, the ﬁnal
match was randomly selected from the pool. Patients with
no matching comparison subject were excluded from the
analysis.
For the analysis, a binary variable was created for each
anomaly such that the presence of an anomaly was scored
qualitatively as present ‘‘1’’ or absent ‘‘0’’.
Paired t-tests were used to examine differences in
morphological features between autistics and controls for
continuous variables, McNemar’s tests for dichotomous
variables and conditional logistic regression for categorical
variables. Exact p values from the McNemar’s test were
used to compare controls and patients on these variables.
Inﬂated alpha levels due to multiple testing were addressed
by using the Holm-Bonferroni approach to adjust p-values.
Statistical signiﬁcance was set at p\.05 (2-tailed) for all
analyses (Holm 1979). Matching and data analysis were
performed using the Statistical Package for the Social
Sciences (SPSS release 15, SPSS Inc., Chicago, IL).
Results
Demographics
The development of the sample for the present study is
summarized in a ﬂowchart (Supp. Fig. 3)
A total of 442 consecutive patients were invited to par-
ticipate; of these, 421 agreed to undergo extensive morpho-
logical assessments (95.2%). The mean age at examination
of the patients was 9.7 years (range 3–18 years), compared
with 10.4 years (range 8–14 years) for controls. The male/
female ratio was 4.19 in patients and 0.93 in controls.
Because of the large age and gender differences between
autistics and controls, analyses were performed on matched
pairs. There were no signiﬁcant group differences between
case and controls with regard to their socioeconomic back-
ground. Supp. Table 1 shows the baseline characteristics for
the entire sample and the matched sample. Among 421
cases, 32 subjects were excluded from the analysis as being
J Autism Dev Disord (2011) 41:23–31 25
123non-Caucasian, 31 were excluded as not fulﬁlling ASD
criteria. Further, 28 children were excluded from the autistic
group due to a diagnosis of a known syndrome or chromo-
somal abnormality (Supp. Table 2).
After matching on age and gender, 224 patients with
autism and 224 controls were available for analysis. Of the
224 matched pairs, 186 (83%) were male, and 38 (17%)
were female. The mean (SD) age of patients was 10.6 (2.5)
years and the mean age of controls was 10.6 (1.4) years.
Quantitative Measurements
The matched pairs were compared on height, weight,
occipitofrontal circumference (OFC), inner canthal dis-
tance (ICD), and outer canthal distance (OCD). The mean
differences between the measured anthropometry are given
in Table 1. Measurement of BMI, weight, OFC, ICD, and
OCD appears to be signiﬁcantly higher in children with
autism than in controls. However, when we stratiﬁed the
data by gender, differences in BMI and OFC were only
statistically signiﬁcant in male children. Both male and
female patients had statistically signiﬁcant larger ICD and
OCD than controls.
Table 1 shows the mean quantitative measurements for
the total matched sample (N = 448 individuals), the female
matched (n = 76), and the male matched sample
(n = 372). There was a signiﬁcant difference in OFC, ICD,
and OCD. The mean OFC, ICD, OCD in children with
ASD were signiﬁcantly larger than the mean in controls
p\0.01. ICD and OCD difference remained signiﬁcant
after controlling for OFC. Furthermore, height and weight
was calculated as covariates to take the potential effects of
general differences in body size into account and to
establish the speciﬁcity of the OFC effect. Differences in
OFC between the autistic and the control group were still
signiﬁcant after controlling for height and weight
(p\.05), suggesting that the observed differences in OFC
were not due to a generalized enlargement in body size. No
differences between autistics and controls were found for
height, middle ﬁnger length, hand palm length, hand length
and foot length.
Occurrence of Morphological Abnormalities in Patients
with ASD
Major abnormalities, minor anomalies and common vari-
ants were signiﬁcantly more prevalent in the patients with
ASD, and patients with ASD had a signiﬁcantly higher
occurrence of combinations of major abnormalities, minor
anomalies and common variants (Fig. 1). One or more
major abnormalities were present in 43.8% of patients
(12.5% in controls, p\.001), two or more abnormalities in
12.1% of patients (0.9% in controls, p\.001), and three or
more abnormalities were found in 3.6% compared with
none in controls (p\.001; Fig. 1). One or more minor
anomalies were found in 98.2% of patients (58.9% in
controls, p\.001), two or more minor anomalies in 89.7%
of patients (25.0% in controls, (p\.001), and three or
Table 1 Quantitative measurements of the body features (paired sample t-test)
Boys only (186 pairs, matched
by age)
Girls only (38 pairs, matched
by age)
Matched sample (total; matched
by sex and age)
Mean difference (SE)
(control-case)
t Mean difference (SE)
(control-case)
t Mean difference (SE)
(control-case)
t
Height (cm) -1.9 (1.1) -1.7 -1.0 (2.4) -0.4 -1.7 (1.0) -1.7
Weight (kg) -4.9 (1.0) -4.5* -3.5 (2.6) -1.3 -4.7 (1.0) -4.7*
BMI (kg/m
2) -1.2 (0.2) -4.3* -1.0 (0.7) -1.3 -1.1 (0.2) -4.4*
OFC (cm)^ -0.5 (0.1) -2.9* -0.2 (0.4) -0.5 -0.4 (0.1) -2.9*
ICD (cm)# -0.1 (0.0) -3.7* -0.2 (0.0) -2.6* -0.1 (0.0) -4.3*
OCD (cm)# -0.8 (0.0) -9.4* -0.7 (0.1) -4.7* -0.8 (0.0) -10.3*
PFL (cm)# -0.3 (0.0) -9.1* -0.2 (0.0) -3.6* -0.3 (0.0) -9.7*
Middle ﬁnger length
(cm)
-0.0 (0.0) -1.7 0.0 (0.1) 0.0 -0.1 (0.0) -1.6
Handpalm length (cm) -0.0 (0.0) -1.0 0.1 (0.1) 0.7 -0.0 (0.0) -0.6
Hand length (cm) -0.2 (0.1) -1.6 0.1 (0.2) 0.4 -0.1 (0.1) -1.3
Foot length cm) -0.1 (0.1) -0.4 0.7 (0.4) 1.5 0.0 (0.1) 0.2
OFC occipito frontal; BMI body mass index; ICD inner Canthal; OCD outer Canthal; PFL palpebral ﬁssure
* statistically signiﬁcant at p\0.05
# controlling for OFC did not change the results
^ controlling for weight, height, ICD and OCD did not changes the results
26 J Autism Dev Disord (2011) 41:23–31
123more minor anomalies were found in 77.7% of patients
compared with 7.1% in controls (p\.001; Fig. 1). One or
more common variants were found in 100% of patients
(89.3% in controls, p\.001), two or more minor anoma-
lies in 98.2% of patients (67.4% in controls, (p\.001),
and three or more minor anomalies were found in 95.5% of
patients compared with 41.1% in controls (p\.001;
Fig. 1).
Furthermore, in a univariate analysis, 63 of the 683
morphological features were found to occur signiﬁcantly
(p\.001) more often in patients compared with controls.
After correction for multiple testing, 48 morphological
abnormalities were signiﬁcantly (p\.05, two-tailed) more
common among patients than controls. The odds ratios
(OR’s) for the occurrence of these anomalies are shown in
Table 2. Thirty-nine of the morphological features were
also signiﬁcantly more common in male matched pairs, and
in two of these, the difference was also signiﬁcantly more
frequent in female matched pairs.
Discussion
We have demonstrated a strikingly high prevalence of
morphological abnormalities in a large cohort of patients
with ASD without mental retardation, compared with
controls. The results support existing research ﬁndings
from a meta-analysis by Ozgen et al. (2010), as well as
those of previous reports in the literature (Steg and Rapo-
port 1975; Walker 1977; Campbell et al. 1978; Gualtieri
et al. 1982; Rodier et al. 1997; Hardan et al. 2006; Miles
et al. 2008). In this present study, we tried to overcome the
methodological limitations that occurred in previous stud-
ies. The main strengths of our study are careful clinical
assessments using stringent morphological characteriza-
tion, robust statistical methods and adequate power relative
to previous studies. This sample size of 224 matched
patient-control pairs is the largest to be studied to date for
morphological features in ASD. Furthermore, in the present
study all patients underwent a clinical morphological
examination, using a list of 683 well-deﬁned morphologi-
cal abnormalities, assessed by the same investigator, and
co-assessed blindly by a second investigator in about 10%.
Several interesting ﬁndings emerged from this study.
First, our study demonstrated that the frequency of mor-
phological anomalies is highly elevated in ASD without
mental retardation, that not only minor anomalies but also
major abnormalities and common variants are signiﬁcantly
more prevalent in children with autism versus controls.
Some of the features may be direct malformations whereas
others might be indirect e.g., open mouth expression, dry
skin, pes planus. This ﬁnding resembles that of an associ-
ation of autism with CNVs, which are common under
normal circumstances, but also are an important aspect of
genomic disorders, i.e., diseases caused by an alteration of
the genome causing complete loss of copy, gain of copy or
disruption of a dosage-sensitive gene (Sebat et al. 2007). In
fact, Engels et al. (2007) showed a direct association
between the severity of physical anomalies and the gene
content of the microdeletions/microduplications.
Second, males with autism showed a trend for more
morphological abnormalities scored than females, i.e.,
males with ASD without mental retardation were notably
having signiﬁcantly more morphological abnormalities
than female patients. Although one has to be cautious in
interpreting these gender differences because of large dif-
ferences in sample size, there are many plausible expla-
nations for the observed differences. An explanation might
be that the human male brain is generally more vulnerable
to endogenous or exogenous factors which are poorly
understood (Mizuno 2000). In addition, sex differences in
brain structure and development are well known (Baron-
Cohen et al. 2005). These results may also substantiate that
some genetic risk factors inﬂuencing liability to autism in
males and females might act differently. Furthermore, in
schizophrenia literature there are ﬁndings parallel to ours
Fig. 1 Prevalence of major
abnormalities, minor anomalies
and common variants in the
matched sample of autistics
versus controls
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123Table 2 Morphological features occurring signiﬁcantly more frequent in children with autism versus controls
Morphological feature Controls
(n = 224)
Autism
(n = 224)
OR (95% CI) p Type of abnormality
§Brachycephaly 0 18 ? (1.5–?) 0.001 Minor anomaly
§#Face asymmetry 4 113 27.6 (19.3–73.9) \0.001 Minor anomaly
§Face coarse 2 27 12.9 (3.2–52.5) \0.001 Minor anomaly
§Forehead prominent 6 53 8.2 (3.5–19) \0.001 Minor anomaly
§Eyes assymetry 0 15 13.7 (2–95.1) 0.001 Minor anomaly
§Eyes deeply set 9 42 6.4 (2.7–15) \0.001 Minor anomaly
§Prominent premaxilla 4 30 7.3 (2.6–20.6) 0.001 Minor anomaly
§Mounth asymmetry 0 23 ? (2.3–?) \0.001 Minor anomaly
Macrostomia 0 14 ? (0.9–?) \0.001 Minor anomaly
Microstomia 2 15 14 (1.8–106) 0.022 Minor anomaly
§Short philtrum 5 35 6.9 (2.7–17.4) \0.001 Minor anomaly
Upper lip cupid bow 5 25 5.9 (2.1–16.7) 0.032 Minor anomaly
§#Palate high/narrow 17 83 5.7 (3.2–10) \0.001 Minor anomaly
§Long uvula 3 23 7.5 (2.3–24.4) Minor anomaly
§Macrodontia/teeth asymmetry/
abnormally shaped teeth
3 33 7.8 (2.8–21.8) \0.001 Minor anomaly
§Ear low-set 1 20 18.3 (2.7–124) 0.004 Minor anomaly
§Ear posteriorly rotated 5 33 10 (3.1–32.2) \0.001 Minor anomaly
Ear lobe crease 0 12 ? (0.6–?) 0.035 Minor anomaly
§Toes syndactyly 2 61 13.9 (3.4–56.2) \0.001 Minor anomaly
§Halluces valgus 4 29 9.1 (2.8–29.3) \0.001 Minor anomaly
§Hypermobile/hyperlax joints 21 74 5.4 (2.9–9.9) \0.001 Minor anomaly
Multiple nevi 9 28 3.2 (1.5–6.8) 0.031 Minor anomaly
Hypo-/depigmentation patches 4 18 5.5 (1.6–18.5) 0.033 Minor anomaly
§Face expression less/dull 0 15 ? (1–?) 0.001 Major abnormality
§Open mouth appearance 0 18 ? (1.5–?) \0.001 Major abnormality
§,
aAbnormal whorl (non-frontal) 0 87 ? (8.4–?) \0.001 Common variant
§Full cheeks 5 31 9.3 (2.9–30) \0.001 Common variant
§Periorbital fullness 8 49 7.7 (3.3–17.9) \0.001 Common variant
§Eyebrows arched 1 37 33.7 (5–?) \0.001 Common variant
§Large nose 4 29 7 (2.5–19.9) 0.002 Common variant
§Nose bridge prominent 28 66 3.5 (1.9–6.2) \0.001 Common variant
§Nose concave 4 27 6.6 (2.3–18.6) 0.006 Common variant
Lower lip full 31 65 2.6 (1.6–4,4) 0.001 Common variant
§Upper lip thin 21 60 3.4 (1.9–5.9) \0.001 Common variant
§Prominent philtrum 5 30 5.9 (2.3–15) 0.004 Common variant
§Lower jaw prominent 0 31 ? (0.6–?) \0.001 Common variant
§Dimpled/grooved chin 1 27 ? (0.5–?) \0.001 Common variant
§Prominent ear 8 40 5.5 (2.4–12.2) \0.001 Common variant
§
,aEar lobes attached 25 78 4 (2.4–6.9) \0.001 Common variant
§Clinodactyly (ﬁngers) 11 40 3.6 (1.8–7) 0.001 Common variant
§Clinodactyly (toes) 9 48 5.8 (2.7–12.2) \0.001 Common variant
Inverted nipples 6 28 4.6 (1.9–11) 0.035 Common variant
Toes widely spaced 1 22 20 (2.9–?) 0.001 Common variant
2nd toe longer than 1st 9 33 4.3 (1.9–9.8) 0.021 Common variant
§Pes planus 4 36 8.8 (3.1–24.4) \0.001 Common variant
§
,aSandal gap (toes) 57 144 4.4 (2.8–6.8) \0.001 Common variant
§Dry skin 12 60 6.9 (3.3–14.4) \0.001 Common variant
28 J Autism Dev Disord (2011) 41:23–31
123regarding a gender effect on the occurrence of morpho-
logical characteristics (McGrath et al. 1995; Akabaliev and
Sivkov 2007).
Third, the pattern of changes in morphological features
was not straightforward. For example, we found that both
smaller and larger mouth size were signiﬁcantly elevated in
patients with ASD compared to controls. Moreover, in
contrast to some previous studies (Hardan et al. 2006;
Rodier et al. 1997), we did not ﬁnd that the presently
studied patients with ASD had smaller ICD. On the con-
trary, we found that our patients had larger ICD and OCD,
a ﬁnding that is consistent with the ﬁndings of Walker
(1977) and Bailey et al. (1995). This observation may
suggest either that the direction of changes in the orbital
distance may be a random outcome of a common neuro-
developmental defect or that these opposite effects may
underlie separate neurodevelopmental defects which might
eventually lead to a better characterization of subgroups of
patients with autism.
Fourth, in a recent meta-analysis in schizophrenia, a
higher prevalence of morphological abnormalities was also
established (Weinberg et al. 2007) with similar overlapping
markers (e.g., brachycephaly; McGrath et al. 2002).
Indeed, there is strong indication that individuals with
schizophrenia may display evidence of craniofacial dys-
morphology. Some evidence for such an overlap comes
from the observation that individuals with ASD may also
be at greater risk for schizophrenia (Mouridsen et al. 2008).
There are certain limitations that should be borne in
mind when interpreting the results. First, although our
sample size provides the necessary statistical power for
quantitative analyses, yet some categorical analyses may
suffer from power limitations due to the relatively small
number of females in the sample. Notably, our sample was
predominantly male. The potential difference in morpho-
logical features found between males and females require
further conﬁrmation.
Second, as morphologic examination requires in-person
examination, it is generally not possible for the raters to be
blind to diagnosis. However, 11% of controls and 9% of
patients were scored independently by two observers,
resulting in high kappa scores. Additionally there were no
prior hypotheses as of which morphological abnormalities
should be associated with autism.
Third, we limited our study population to Caucasian
patients and controls as ethnicity can inﬂuence the preva-
lence of morphological abnormalities. Future studies are
needed to establish similar norms for other ethnic groups.
Likewise, we restricted ourselves to non-mentally retarded
ASD patients. Therefore, we cannot generalize our ﬁndings
to mentally retarded ASD patients or patient subgroups.
Forth, it is typically quite a challenge to determine
whether these features are risk factors. The possible causal
relevance of the association between disturbed prenatal
development and subsequent autism has stimulated con-
siderable discussion. In the present consideration of cau-
sality, we do not suggest that abnormal morphology in
itself causes autism. In addition, we acknowledge that there
are many disorders with similar morphological character-
istics. e.g., increased head size. The same feature has
already been shown to be related to a particular SNP var-
iant in people with autism (Conciatori et al. 2004) as well
as in people without a diagnosis (Muscarella et al. 2007).
On the other hand, people with a very different etiology for
autism, in utero exposure to valproic acid, also exhibit
increased head size (Rasalam et al. 2005). Further studies
are needed to discover the speciﬁcity, sensitivity and pre-
dictive value of these features for ASD. Moreover, some of
the morphological characteristics among families may not
be related to the ASD; demonstrating a genetic component
independent of any syndrome and condition. Therefore, we
recommend sib comparisons as future studies.
Last, the goal of this analysis was to provide a detailed
analysis for the association of morphological features and
ASD without mental retardation. We have not been able to
address other intriguing questions such as clustering of the
morphological features in different subgroups of ASD.
These associations probably exist but are beyond the scope
of this study. While we did not intend to establish speci-
ﬁcity of single phenotypic characteristics to speciﬁc sub-
types of ASD, we consider it possible that sets of physical
anomalies might be related to severity of illness, or those
speciﬁc phenotypic behavioral characteristics may deﬁne
even more subtypes of ASD.
The current ﬁndings may have implications for future
research, psychiatric nosology and clinical practice. With
regard to future research implications, our ﬁndings help to
reconcile previous puzzling evidence about the relationship
Table 2 continued
Morphological feature Controls
(n = 224)
Autism
(n = 224)
OR (95% CI) p Type of abnormality
§Nails striped 1 41 37.3 (5.6–?) \0.001 Common variant
a MPA in Waldrop scale # Signiﬁcant in girls (p\0.05) § Signiﬁcant in boys (p\0.05) Forty-eight morphological features occurring
signiﬁcant more frequently in patients with autism compared to controls in univariate analysis (McNemar’s test p\0.05; Holm–Bonferroni
corrected)
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123between morphological features and ASD such as the
inconsistency of this association across topographical
areas. With regard to psychiatric nosology, our study adds
to a growing body of research that suggests that morpho-
logical features might identify subgroups of individuals
with ASD. It is possible that a subgroup of individuals with
a higher number of unusual morphological ﬁndings or
speciﬁc combinations of morphological ﬁndings is at
highest risk of developing ASD without mental retardation.
With regard to implications for clinical practice, our results
support the importance of measuring morphological fea-
tures in individuals with ASD. We suggest that routine
assessment of quantitative and qualitative measurements
could provide clinicians with necessary information to
homogenise the ASD. In turn, the early recognition of the
risk associated with morphological abnormalities might
help to address pressing needs for the care of individuals
with ASD.
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